Citation Impact
Citing Papers
The HER-2 Receptor and Breast Cancer: Ten Years of Targeted Anti–HER-2 Therapy and Personalized Medicine
2009
MK-2206, an Allosteric Akt Inhibitor, Enhances Antitumor Efficacy by Standard Chemotherapeutic Agents or Molecular Targeted Drugs In vitro and In vivo
2010 Standout
Efficacy and Safety of Trastuzumab as a Single Agent in First-Line Treatment of HER2-Overexpressing Metastatic Breast Cancer
2002 Standout
A feasibility double-blind randomized placebo-controlled trial of extracorporeal shockwave therapy as a novel treatment for intermittent claudication
2017 StandoutNobel
Trastuzumab Emtansine for HER2-Positive Advanced Breast Cancer
2012 Standout
Predictors of Postoperative Pain and Analgesic Consumption
2009 Standout
Untangling the ErbB signalling network
2001 Standout
Resistance to tamoxifen‐induced apoptosis is associated with direct interaction between Her2/neu and cell membrane estrogen receptor in breast cancer
2001
Even Low-level HER2 Expression May be Associated With Worse Outcome in Node-positive Breast Cancer
2009
The c-erbB-2 proto-oncogene as a prognostic and predictive marker in breast cancer: A paradigm for the development of other macromolecular markers-A review
1995
Targeted Therapy in Breast Cancer
2004
Akt is frequently activated in HER2/neu-positive breast cancers and associated with poor prognosis among hormone-treated patients
2005
Recommendations for Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Clinical Practice Guideline Update
2013 Standout
The relationship between prognostic and predictive factors in the management of breast cancer
1998
Multinational Study of the Efficacy and Safety of Humanized Anti-HER2 Monoclonal Antibody in Women Who Have HER2-Overexpressing Metastatic Breast Cancer That Has Progressed After Chemotherapy for Metastatic Disease
1999 Standout
Comparison of Fluorescence In Situ Hybridization and Immunohistochemistry for the Evaluation of HER-2/neu in Breast Cancer
1999
Development of a Purine-Scaffold Novel Class of Hsp90 Binders that Inhibit the Proliferation of Cancer Cells and Induce the Degradation of Her2 Tyrosine Kinase
2002
Extracorporeal shockwave therapy for the treatment of lower limb intermittent claudication: study protocol for a randomised controlled trial (the SHOCKWAVE 1 trial)
2017 StandoutNobel
Immunofluorescent labeling of cancer marker Her2 and other cellular targets with semiconductor quantum dots
2002 Standout
ERBB receptors and cancer: the complexity of targeted inhibitors
2005 Standout
Gene Expression and Benefit of Chemotherapy in Women With Node-Negative, Estrogen Receptor–Positive Breast Cancer
2006 Standout
The estimation of a preference-based measure of health from the SF-36
2002 Standout
Short-term and long-term effects of caesarean section on the health of women and children
2018 Standout
Psychosocial Influences on Women’s Experience of Planned Elective Cesarean Section
2006
Epilepsy genetics — past, present, and future
2011
Factors relating to the infant's last sleep environment in sudden infant death syndrome in the Republic of Ireland
2003
Taxanes, microtubules and chemoresistant breast cancer
2007
Efficacy and safety of neoadjuvant pertuzumab and trastuzumab in women with locally advanced, inflammatory, or early HER2-positive breast cancer (NeoSphere): a randomised multicentre, open-label, phase 2 trial
2011 Standout
Involvement of chemokine receptors in breast cancer metastasis
2001 StandoutNature
Maternal separation disrupts dendritic morphology of neurons in prefrontal cortex, hippocampus, and nucleus accumbens in male rat offspring
2010
HSP90 and the chaperoning of cancer
2005 Standout
EGF–ERBB signalling: towards the systems level
2006 Standout
Cardiovascular and musculoskeletal response to supervised exercise in patients with intermittent claudication
2018 StandoutNobel
Rapid Single-Step Induction of Functional Neurons from Human Pluripotent Stem Cells
2013 StandoutNobel
Exercise Therapy or Angioplasty? A Summation Analysis
2000
Methods of assessment of iodine status in humans: a systematic review
2009 Standout
Trastuzumab — Mechanism of Action and Use in Clinical Practice
2007 Standout
Altered dendritic spine density in animal models of depression and in response to antidepressant treatment
2001
Caesarean Delivery and Subsequent Stillbirth or Miscarriage: Systematic Review and Meta-Analysis
2013
Design and fabrication of magnetic nanoparticles for targeted drug delivery and imaging
2009 Standout
Autoradiographic localization of dopamine D1 and D2 receptors in rat nucleus accumbens: Resistance to differential rearing conditions
1991 Standout
Neurobiology of Depression
2002 Standout
Benefits and Harms Associated With the Practice of Bed Sharing
2007
Tumour-educated macrophages promote tumour progression and metastasis
2004 Standout
Selenium in global food systems
2001
A Multigene Assay to Predict Recurrence of Tamoxifen-Treated, Node-Negative Breast Cancer
2004 Standout
Paracrine and autocrine growth mechanisms in tumor metastasis to specific sites with particular emphasis on brain and lung metastasis
1993
Quality of life analysis in patients with lower limb ischaemia: Suggestions for European standardisation
1997
Managing the care of adults with Down's syndrome
2014
Effects of successful percutaneous lower extremity revascularization on cardiovascular outcome in patients with peripheral arterial disease
2012
Natural compounds for cancer treatment and prevention
2009 Standout
Use of Chemotherapy plus a Monoclonal Antibody against HER2 for Metastatic Breast Cancer That Overexpresses HER2
2001 Standout
Pertuzumab plus Trastuzumab plus Docetaxel for Metastatic Breast Cancer
2011 Standout
Fibroblasts in cancer
2006 Standout
Plasticity of the dendritic spine
1993
Zoonotic parasites in fecal samples and fur from dogs and cats in The Netherlands
2009
Down syndrome
2020 Standout
Biofortification of crops with seven mineral elements often lacking in human diets – iron, zinc, copper, calcium, magnesium, selenium and iodine
2009 Standout
Prevalence of intestinal parasites and genotyping of Giardia intestinalis in pet shop puppies in east Japan
2010
Epidermal growth factor receptor (EGFR) signaling in cancer
2005 Standout
Estrogen Actions in the Central Nervous System1
1999 Standout
Sudden unexplained infant death in 20 regions in Europe: case control study
2004
Ohtahara syndrome with emphasis on recent genetic discovery
2011
Breast cancer metastasis: markers and models
2005 Standout
Value of a supervised exercise program for the therapy of arterial claudication
1997
Zoonotic Potential and Molecular Epidemiology ofGiardiaSpecies and Giardiasis
2011 Standout
Long-term outcomes of a randomized clinical trial of supervised exercise, percutaneous transluminal angioplasty or combined treatment for patients with intermittent claudication due to femoropopliteal disease
2016 StandoutNobel
The HER‐2/ neu Oncogene in Breast Cancer: Prognostic Factor, Predictive Factor, and Target for Therapy
1998
ACC/AHA 2005 Practice Guidelines for the Management of Patients With Peripheral Arterial Disease (Lower Extremity, Renal, Mesenteric, and Abdominal Aortic)
2006 Standout
SIDS and Other Sleep-Related Infant Deaths: Expansion of Recommendations for a Safe Infant Sleeping Environment
2011 Standout
2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines
2019 Standout
Infant Arousals During Mother-Infant Bed Sharing: Implications for Infant Sleep and Sudden Infant Death Syndrome Research
1997
Methods of estimation of spine density--are spines evenly distributed throughout the dendritic field?
1991
Cardiac Dysfunction in the Trastuzumab Clinical Trials Experience
2002 Standout
Abnormal dendritic spines in fragile X knockout mice: Maturation and pruning deficits
1997 Standout
Progression to Malignancy in the Polyoma Middle T Oncoprotein Mouse Breast Cancer Model Provides a Reliable Model for Human Diseases
2003 Standout
Effect of a Sudden Infant Death Syndrome Risk Reduction Education Program on Risk Factor Compliance and Information Sources in Primarily Black Urban Communities
2003
Evaluating non-randomised intervention studies
2003 Standout
A review of the use of health status measures in economic evaluation.
1999
The HER-2/neu Gene and Protein in Breast Cancer 2003: Biomarker and Target of Therapy
2003
Exercise as medicine – evidence for prescribing exercise as therapy in 26 different chronic diseases
2015 Standout
About Sleep's Role in Memory
2013 Standout
Role of HER2 gene overexpression in breast carcinoma
2000
Impact of Natural Products on Developing New Anti-Cancer Agents
2009 Standout
Efficacy and Safety of Trastuzumab as a Single Agent in First-Line Treatment of HER2-Overexpressing Metastatic Breast Cancer
2002 Standout
Inspired CO2and O2in sleeping infants rebreathing from bedding: relevance for sudden infant death syndrome
2001
The HER‐2/ neu Oncogene in Breast Cancer: Prognostic Factor, Predictive Factor, and Target for Therapy
1998
Tenascin expression in cancer cells and stroma of human breast cancer and its prognostic significance.
1995
Value of Primordial and Primary Prevention for Cardiovascular Disease
2011
2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines
2019 Standout
Works of M O'Regan being referenced
Prognostic significance of c-erbB-2 and estrogen receptor status in human breast cancer.
1991
Quality of life following percutaneous transluminal angioplasty for claudication
1996
CDKL5 mutations cause infantile spasms, early onset seizures, and severe mental retardation in female patients
2006
Ocular Toxocariasis in Schoolchildren
2004
Neural plasticity of the hippocampal (CA1) pyramidal cell--quantitative changes in spine density following handling and injection for drug testing.
1991
Serum selenium levels in individuals on PKU diets
1991
Arousal responses in babies at risk of sudden infant death syndrome at different postnatal ages.
1992
Smoking: the major risk factor for SIDS in Irish infants.
2002
Reduce the risk of cot death guidelines. The effect of a revised intervention programme. National Sudden Infant Death Register, Dublin.
1999
Rising caesarean section rates: a cause for concern?
2003
Guidelines for the medical management of Irish children and adolescents with Down syndrome.
2005